v3.23.3
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Total revenue $ 6,796 $ 4,240 $ 50,290 $ 17,143
Operating expenses:        
Research and development 7,624 21,973 40,079 64,835
General and administrative 4,309 5,934 15,306 20,120
Total operating expenses 11,933 27,907 55,385 84,955
Loss from operations 5,137 23,667 5,095 67,812
Interest and other income, net 210 307 1,030 563
Interest and other expense, net [1] (31) (1,224) (2,615) (3,365)
Gain on extinguishment of debt     1,795  
Change in valuation of contingent value right (Note 5) 881   1,184  
Loss on disposal of property and equipment [1] (76) (28) (475) (29)
Loss before provision for income taxes 4,153 24,612 4,176 70,643
Provision for income taxes   26   26
Net loss attributable to common shareholders $ 4,153 $ 24,638 $ 4,176 $ 70,669
Net loss per share attributable to common stockholders:        
Basic $ 0.82 $ 6.56 $ 0.99 $ 18.82
Diluted $ 0.82 $ 6.56 $ 0.99 $ 18.82
Weighted average number of shares used in net income per share calculations:        
Basic 5,092,859 3,756,658 4,206,986 3,755,178
Diluted 5,092,859 3,756,658 4,206,986 3,755,178
Research and development revenue        
Total revenue $ 5,732 $ 4,240 $ 45,986 $ 17,143
Grant revenue        
Total revenue $ 1,064 $ 0 $ 4,304 $ 0
[1] Loss on disposal of property and equipment was included in interest and other expense, net in the prior year presentation.

Source